Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Descripció completa

Dades bibliogràfiques
Autors principals: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Format: Article
Idioma:English
Publicat: Taylor & Francis Group 2019-06-01
Col·lecció:CNS Oncology
Matèries:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Accés en línia:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Internet

https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Ítems similars